FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH TrialBusiness Wire • 07/02/25
Merck Foundation Chairman, CEO, and 14 First Ladies Inaugurate the 7th Edition of Merck Foundation First Ladies Initiative - MFFLI Summit in DubaiBusiness Wire • 07/01/25
Merck's RSV shot for infants gets key approval despite RFK Jr.'s panel shakeupFast Company • 06/26/25
ACIP Recommends Use of Merck's ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV SeasonBusiness Wire • 06/26/25
Will MRK's Growing Pipeline Help Navigate the Looming Keytruda LOE?Zacks Investment Research • 06/26/25
MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets GoalZacks Investment Research • 06/24/25
Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and PreventionBusiness Wire • 06/24/25
Merck Announces Phase 3 HYPERION Study of WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Recently Diagnosed Adults with Pulmonary Arterial Hypertension (PAH)Business Wire • 06/23/25
IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Pretreated Metastatic Castration-Resistant Prostate CancerBusiness Wire • 06/18/25